In vivo site-directed mutagenesis of the factor IX gene by chimetic RND/DNA oligonucleotides

Nature Medicine

Volumn 4, Issue 3, 1998, Pages 285-290

  Kren, Betsy T ^a   Banoyopaohyay, Paramtta ^a   Steer, Clifford J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; DNA; OLIGONUCLEOTIDE; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; LIVER CELL CULTURE; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; POINT MUTATION; PRIORITY JOURNAL; RAT; SITE DIRECTED MUTAGENESIS;

ANIMALS; BIOLOGICAL TRANSPORT; CELL SEPARATION; CELLS, CULTURED; CLONING, MOLECULAR; FACTOR IX; GENE TARGETING; LIVER; MALE; MUTAGENESIS, SITE-DIRECTED; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES; OLIGORIBONUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE ANALYSIS, DNA; SERINE; TRANSFECTION;

ANIMALIA;

EID: 0031953132     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0398-285     Document Type: Article

References (41)

1. Chang, A.G.Y. & Wu, G.Y. Gene therapy: Applications to the treatment of gastrointestinal and liver diseases. Gastroenterology 106, 1076-1084 (1994).
2. 1antitrypsin deficiency. Hepotology 24, 1504-1516 (1996).
3. Reiner, A.P. & Davie, E.W. In The Metabolic and Molecular Bases of Inherited Disease. (eds. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 3181-3221 (McGraw-Hill, Inc., New York, 1995).
4. Strauss, M. Liver-directed gene therapy: Prospects and problems. Gene Ther. 1, 156-164 (1994).
5. Bowles, N. & Woo, S.L.C Gene therapy for metabolic disorders. Advanced Drug Del. Rev. 17, 293-302 (1995).
6. Askari, F.K., Hitomi Y., Mao, M. & Wilson, J.M. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase. Gene Ther. 3, 381-388 (1996).
7. Ye, X. et al Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors, J. Biol Chem. 271, 3639-3646 (1996).
8. Connelly, S., Gardner, J.M., Lyons, R.M., McClelland, A. & Kaleko, M. Sustained expression of therapeutic levels of human factor VIII in mice. Blood87, 4671-4677 (1996).
9. Takahashi, M. et al Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period. J. Biol. Chem, 271, 26536-26542 (1996).
10. Ilan, Y. et al Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J. Clin. Invest. 99, 1098-1106 (1997).
11. Wang, G., Levy, D.D., Seidman, M.M. & Glazer, P.M. Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol. Cell. Biol. 15, 1759-1768 (1995).
12. Beal, P.A. & Dervan, P.B. Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation. Science 251, 1360-1363 (1991).
13. Thomas, K.R. & Capecchi, M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512 (1987).
14. Zheng, H. & Wilson, J.H. Gene targeting in normal and amplified cell lines. Nature 344, 170-173 (1990).
15. Sakagami, K., Tokinaga Y., Yoshikura, H. & Kobayashi, I. Homology-associated nonhomologous recombination in mammalian gene targeting. Proc. Natl. Acad. Sci. USA 91, 8527-8531 (1994).
16. Yoon, K., Cole-Strauss, A. & Kmiec, E.B. Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA·DNA oligonucleotide. Proc. Natl. Acad. Sci. USA 93, 2071-2076 (1996).
17. Cole-Strauss, A. et al. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science 273, 1386-1389 (1996).
18. Kmiec, E.B., Cole, A. & Holloman, W.K. The REC2 gene encodes the homologous pairing protein of Ustilago maydis. Mol. Cell. Biol. 14, 7163-7172 (1994).
19. Kotani, H. et al. RNA facilitates RecA-mediated DNA pairing and strand transfer between molecules bearing limited regions of homology. Mol. Gen. Genet. 250, 626-634 (1996).
20. Monia, B.P. et al. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268, 14514-14522 (1993).
21. Shinohara, A. & Ogawa, T. Homologous recombination and the roles of doublestrand breaks. Trends Biochem. Sci. 20, 387-391 (1995).
22. Kolodner, R.D. Mismatch repair: Mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci. 20, 397-401 (1995).
23. Kren, B.T., Cole-Strauss, A., Kmiec, E.B. & Steer, C.J. Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotide. Hepatology 25, 1462-1468 (1997).
24. Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297-7301 (1995).
25. Sarkar, G., Koeberl, D.D. & Sommer, S.S. Direct sequencing of the activation peptide and the catalytic domain of the factor IX gene in six species. Genomics 6, 133-143 (1990).
26. Wong, E.A. & Capecchi, M.R. Homologous recombination between coinjected DNA sequences peaks in early to mid-S phase. Mol. Cell. Biol. 7, 2294-2295 (1987).
27. Yamamoto, A. et al. Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells. Mol. Gen. Genet. 251, 1-12 (1996).
28. Stürzbecher, H.-W., Donzelmann, B., Henning W., Kippschild, U. & Buchhop, S. p53 is linked directly to homologous recombination processes via RAD51 /RecA protein interaction. EMBO J. 15, 1992-2002 (1996).
29. Fang, W.-h. & Modrich, P. Human strand-specific mismatch repair occurs by a bidirectional mechanism similar to that of the bacterial reaction. J. Biol. Chem. 268, 11838-11844 (1993).
30. Umar, A., Boyer, J.C. & Kunkel, T.A. DNA loop repair by human cell extracts. Science 266, 814-816 (1994).
31. Klungland, A. & Lindahl, T. Second pathway for completion of human DNA base excision-repair: Reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J. 16, 3341-3348 (1997).
32. Wood, R.D. Nucleotide excision repair in mammalian cells. J. Biol. Chem. 272, 23465-23468 (1997).
33. Wellinger, R.E. & Thoma, F. Nucleosome structure and positioning modulate nucleotide excision repair in the non-transcribed strand of an active gene. EMBO J. 16, 5046-5056 (1997).
34. 1-antitrypsin gene expression in somatic cell hybrids: Evidence for multiple controls. Genes Dev. 6, 316-327 (1992).
35. Prouty, S.M. et al. A cell culture model system for genetic analyses of the cell cycle by targeted homologous recombination. Oncogene 8, 899-907 (1993).
36. Arbonés, M.L., Austin, H.A., Capon, D.J. & Greenburg, G. Gene targeting in normal somatic cells: Inactivation of the interferon-γ receptor in myoblasts. Nature Gen. 6, 90-97 (1994).
37. Fan, G., Ma, X., Kren, B.T. & Steer, C.J. The retinoblastoma gene product inhibits TGF-βl induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene 12, 1909-1919 (1996).
38. Gray, G.R. The direct coupling of oligosaccharides to proteins and derivatized gels. Arch. Biochem. Biophys. 163, 426-428 (1974).
39. Abdallah, B. et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum. Gene Ther. 7, 1947-1954 (1996).
40. Kren, B.T., Trembley, J.H. & Steer, C.J. Alterations in mRNA stability during rat liver regeneration. Am. J. Physiol. 270, G763-G777 (1996).
41. Melchior, W.B. & Von Hippel, P.H. Alteration of the relative stability of dA.dT and dG.dC base pairs in DNA. Proc Natl. Acad. Sci. USA 70, 298-302 (1973).